EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening

Daniel F Carvalho iD, Helena P Lima-Valassi iD, Giselle Y Hayashi, Ana C M Oliveira iD, Gustavo S S Matias, Atecla N L Alves, Mirela C Miranda iD, Mariana Funari, Guiomar Madureira, Ana Claudia Latrônico iD, Berenice B Mendonca iD, Tania A S S Bachega iD

The Journal of Clinical Endocrinology & Metabolism · 15.07.2026 · 111 (8) · 2210-2219

DOI: 10.1210/clinem/dgag107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 11.03.2026. Verfasst von Daniel F Carvalho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Hormônios e Genética Molecular - LIM/42, Unidade de Endocrinologia do Desenvolvimento, Disciplina de Endocrinologia e Metabologia, Hos…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, 17-alpha-Hydroxyprogesterone, Neonatal Screening. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The main challenge in congenital adrenal hyperplasia newborn screening (NBS) is the high rate of false-positive results, emphasizing the need for specific serum confirmatory tests. Data on the effectiveness of serum 17-hydroxyprogesterone (17OHP) measurements using available methodologies remain limited.

Objectives

To evaluate the efficacy of confirmatory tests using measurements of serum steroids by radioimmunoassay (RIA) and liquid chromatography tandem mass spectrometry (LC-MS/MS) methodologies. Design and Setting A prospective longitudinal cohort study. Patients Data of 708 437 newborns (NBs) were evaluated.

Methods

Neonatal-17OHP (N17OHP) results ≥ 2 × 99.5th were recalled for serum dosages by RIA (17OHP), by LC-MS/MS (17OHP, 21-deoxycortisol-21DF, androstenedione-Δ4, and cortisol) and positive predictive values (PPV) were determined. Altered hormonal results were submitted to CYP21A2 genotyping. Nonparametric tests and receiver operating characteristic (ROC)-curves were used.

Results

Recall rate of N17OHP (first tier) was 0.03% and serum 17OHP levels remained increased in 26% (RIA) and 11% (LC-MS/MS) of NBs, yielding PPV of 30% and 49%, respectively. Fifty-eight NBs were diagnosed with classical forms, and 32 asymptomatic NBs persisted with increased serum 17OHP levels. ROC-curves between false and true-positive tests disclosed highest diagnostic performance for 17OHP/LC-MS/MS [cutoff 48.3 ng/mL (146.3 nmol/L) = 100%-sensitivity]. The (17OHP+Δ4)/cortisol ratio presented the highest discriminative ability (cutoff 24.9 = 100%-PPV); serum 21DF presented a good performance and was comparable to 17OHP measured by LC-MS/MS (99%-specificity).

Conclusion

Measurement of 17OHP by LC-MS/MS provides the best performance for serum confirmatory tests and may be complemented by the (17OHP+Δ4)/cortisol ratio analysis. Genotyping is useful mainly to resolve persistently indeterminate biochemical results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, Congenital17-alpha-HydroxyprogesteroneNeonatal ScreeningHumansFalse Positive ReactionsInfant, NewbornRadioimmunoassayChromatography, LiquidFemaleTandem Mass SpectrometryProspective StudiesMaleLongitudinal StudiesSteroid 21-HydroxylaseHydrocortisoneCortodoxone

Stichwörter der Autor:innen

17-hydroxyprogesterone21-deoxycortisol21-hydroxylase deficiencyliquid chromatography with tandem mass spectrometrynewborn screeningserum tests

Substanzen

17-alpha-HydroxyprogesteroneSteroid 21-HydroxylaseHydrocortisoneCYP21A2 protein, humanCortodoxone

Autor:innen und Institutionen

  • Laboratório de Hormônios e Genética Molecular - LIM/42, Unidade de Endocrinologia do Desenvolvimento, Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo…
  • Laboratório de Cromatografia e Espectrometria de Massa (AE06-LCMS), Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-900, Brasil.
  • Instituto Jô Clemente, São Paulo 04040-033, Brasil.

ORCID-Profile: Daniel F Carvalho, Helena P Lima-Valassi, Ana C M Oliveira, Mirela C Miranda, Ana Claudia Latrônico, Berenice B Mendonca, Tania A S S Bachega

Förderung

  • FAPESP

Zitieren

APA

Carvalho, D. F., Lima-Valassi, H. P., Hayashi, G. Y., Oliveira, A. C. M., Matias, G. S. S., Alves, A. N. L., Miranda, M. C., Funari, M., Madureira, G., Latrônico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026). Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening. The Journal of Clinical Endocrinology & Metabolism, 111(8), 2210-2219. https://doi.org/10.1210/clinem/dgag107

Vancouver

Carvalho DF, Lima-Valassi HP, Hayashi GY, Oliveira ACM, Matias GSS, Alves ANL, et al. Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening. The Journal of Clinical Endocrinology & Metabolism. 2026;111(8):2210-2219. doi:10.1210/clinem/dgag107

BibTeX
@article{Carvalho2026,
  author = {Carvalho, Daniel F and Lima-Valassi, Helena P and Hayashi, Giselle Y and Oliveira, Ana C M and Matias, Gustavo S S and Alves, Atecla N L and Miranda, Mirela C and Funari, Mariana and Madureira, Guiomar and Latrônico, Ana Claudia and Mendonca, Berenice B and Bachega, Tania A S S},
  title = {Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {8},
  pages = {2210--2219},
  doi = {10.1210/clinem/dgag107}
}
Kostenlos starten →